EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Network Pharmacology and Metabolomics to Decipher the Mechanisms Underlying the Therapeutic Effects of Wuzhi Dripping Pills Against MASLD

Huijun Wang, Miaoyuan Zhang, Kangkang Gao, Yaping Zhou, Aoxing Xiao, Jinyi Liu, Xiangjun Qiu iD

Metabolites · 22.08.2026 · 16 (9) · 601

DOI: 10.3390/metabo16090601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 22.08.2026. Verfasst von Huijun Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Pingdingshan University, Pingdingshan 467000, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a progressive condition predisposing to cirrhosis and hepatocellular carcinoma, with prevalence rising globally. Yet effective therapies remain limited. Wuzhi Dripping Pills (WZDP), derived from Schisandra sphenanthera, possess hepatoprotective and anti-inflammatory properties, though their efficacy against MASLD remains unexplored.

Methods

Network pharmacology predicted active ingredients and targets, followed by KEGG enrichment analysis. A high-fat diet MASLD rat model was established to evaluate WZDP effects on weight, liver index, and serum markers. Serum metabolomic profiling via UPLC-MS/MS, combined with multivariate statistics and KEGG annotation, identified perturbed pathways.

Results

Twelve bioactive compounds and 434 WZDP targets were retrieved, of which 74 intersected with 838 MASLD-associated genes. Enrichment implicated AGE-RAGE, insulin resistance, and HIF-1 signaling. In vivo, WZDP significantly improved anthropometric and biochemical parameters. Metabolomic analysis distinctly separated WZDP-treated from model groups, highlighting phospholipase D signaling as a key differential pathway.

Conclusions

This integrative approach confirms that WZDP confers therapeutic benefits in MASLD through coordinated regulation of neuroactive ligand–receptor interaction, bile acid biosynthesis, phospholipase D signaling, and arginine–proline metabolism. Our findings furnish a molecular and metabolic rationale for further mechanistic studies and drug discovery efforts.

Schlagwörter

Stichwörter der Autor:innen

MASLDWuzhi Dripping Pillsmetabolomicsnetwork pharmacology

Autor:innen und Institutionen

  • School of Medicine, Pingdingshan University, Pingdingshan 467000, China.
  • College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang 471023, China.

ORCID-Profile: Xiangjun Qiu

Zitieren

APA

Wang, H., Zhang, M., Gao, K., Zhou, Y., Xiao, A., Liu, J., & Qiu, X. (2026). Integrating Network Pharmacology and Metabolomics to Decipher the Mechanisms Underlying the Therapeutic Effects of Wuzhi Dripping Pills Against MASLD. Metabolites, 16(9), 601. https://doi.org/10.3390/metabo16090601

Vancouver

Wang H, Zhang M, Gao K, Zhou Y, Xiao A, Liu J, et al. Integrating Network Pharmacology and Metabolomics to Decipher the Mechanisms Underlying the Therapeutic Effects of Wuzhi Dripping Pills Against MASLD. Metabolites. 2026;16(9):601. doi:10.3390/metabo16090601

BibTeX
@article{Wang2026,
  author = {Wang, Huijun and Zhang, Miaoyuan and Gao, Kangkang and Zhou, Yaping and Xiao, Aoxing and Liu, Jinyi and Qiu, Xiangjun},
  title = {Integrating Network Pharmacology and Metabolomics to Decipher the Mechanisms Underlying the Therapeutic Effects of Wuzhi Dripping Pills Against MASLD},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {9},
  pages = {601},
  doi = {10.3390/metabo16090601}
}
Kostenlos starten →